Gelatins
They are commonly used in a variety of applications, including food, pharmaceuticals, and biomedical materials.
Gelatins possess unique physical and chemical properties, such as gelling, thickening, and emulsifying capabilities, making them versatile ingredients.
Researching the properties and applications of different gelatin types is an active area of scientific inquiry, with studies exploring factors like source, processing, and molecular structure.
Proper experimental design and data analysis are crucial for advancing the field of gelatin research and ensuring reproducible, accurate findings.
Pubcomapre.ai offers an AI-driven platform to help optimise gelatin studies, providing access to the best protocols from literature, preprints, and patents, and delivering data-driven insights to enhance reproducibility and accuracy.
Experiecnce the future of gelatin research with Pubcompare.ai today!
Most cited protocols related to «Gelatins»
Most recents protocols related to «Gelatins»
Example 1
Exemplary capsule shell and matrix compositions useful for producing Liquisoft capsules as described herein are shown in Table 4. Composition components are set forth by weight percentage of the total weight of the composition. Such compositions may be encapsulated using rotary die encapsulation as described herein.
Formulas 1 and 2 were the first shell formulations developed to achieve faster disintegration time and prevent crosslinking of the gelatin shell with matrix fill components.
Example 10
Spray-dried disodium FDKP/insulin powder as described in Examples 6 or 7 is packed into hard gelatin capsules. The capsules can contain approximately 50-100 mg of powder. The FDKP salt/insulin powders prepared in Examples 6 and 7 were 25% insulin by weight and insulin activity was about 26 units/mg. Thus, 50 mg would be on the order of 1300 units, significantly larger than a typical dose. About 2-30 mg of the FDKP salt/insulin powder is mixed with methyl cellulose (other bulking agents are well known in the art) to make up the balance of the desired mass.
EXAMPLE 2
-
- 1) Dissolve Gelatin and other ingredients in purified water under stirring at 200-500 rpm.
- 2) Make up the final volume of the solution using purified water.
- 3) Mix the solution under stirring at 200 to 500 rpm for further 15 min.
- 4) Dose the solution into each cavity of preformed blister sheets (preferably using dispensing pipette).
- 5) Freeze the filled blisters at a temperature in the range of −20 to −110° C.
- 6) Freeze dry the blisters in a lyophilizer.
- 7) Place the blister sheet containing dried lyophilisates on the punched carrier web of the blister packaging machine to transport the blister sheets through the sealing station of the packaging machine
- 8) Seal the blister with a lidding foil and punch into final blisters.
Example 6
A gel mass can be prepared in order to encapsulate the pharmaceutical compositions of the various Examples herein.
Gel mass compositions were formulated and produced according to the following steps. Purified water (22.2 kg) and glycerin (10.8 kg) were charged into a stainless steel tank with mixing and heated to a temperature of 80±5° C. Hydrolyzed gelatin (1.8 kg) and gelatin 200 bloom limed bone, NF (24.0 kg) were then added to the water/glycerin mixture and were mixed until all solids were completely dissolved. This resulted in the formation of a gel mass. The resulting gel mass was de-gassed under vacuum. Coloring agents OPATINT® white (0.6 kg) and OPATINT® red (0.6 kg) were then added to the gel mass and the resultant was mixed for about 5 minutes. The resultant was then de-gassed under vacuum for a sufficient period of time and ultimately passed to an encapsulation device for preparation of gel capsules of the types disclosed herein.
Example 1
The pluripotent stem cell line H9 was obtained from NIH line WA 09, supplied by WiCell (Madison, Wis.) and was maintained in an undifferentiated state by passaging on irradiated human foreskin fibroblasts (line HS27, ATCC, Manassas, Va.) and gelatin coated plates. To differentiate the pluripotent stem cells towards a mesodermal and then mesenchymal lineage, the colonies of the pluripotent stem cells were mechanically dissected into small pieces under microscopic guidance and then transferred to tissue culture-treated 6-well plates (Corning). The cells at this stage were considered passage 0 (P0). The cells were cultured in DMEM/F12 supplemented with non-essential amino acids and 10% fetal bovine serum (FBS, Invitrogen-Gibco, Grand Island, N.Y.). When the culture approached confluency, cells were trypsinized and transferred to a new tissue culture flask.
Top products related to «Gelatins»
More about "Gelatins"
These versatile materials possess unique physical and chemical properties, such as gelling, thickening, and emulsifying capabilities, making them widely applicable in the food, pharmaceutical, and biomedical industries.
Gelatin research is an active area of scientific inquiry, with researchers exploring factors like source, processing, and molecular structure to understand and optimize gelatin's performance.
Experiecnce the future of gelatin research with PubCompare.ai, an AI-driven platform that helps scientists optimize their gelatin studies.
PubCompare.ai provides access to the best protocols from literature, preprints, and patents, and delivers data-driven insights to enhance the reproducibility and accuracy of gelatin-related experiments.
Researchers can also leverage related terms and concepts, such as FBS (Fetal Bovine Serum), Penicillin/Streptomycin, L-Glutamine, Non-Essential Amino Acids, DMEM (Dulbecco's Modified Eagle Medium), GlutaMAX, Triton X-100, and Streptomycin, to further enhance their understanding and application of gelatin in various scientific and industrial contexts.
Discover the power of PubCompare.ai and unlock the full potential of your gelatin research today.